China NMPA Drug Inspection - Jiangsu Yuanyang Pharmaceutical Co., Ltd. - pawpaw
China NMPA drug inspection for Jiangsu Yuanyang Pharmaceutical Co., Ltd. published October 12, 2019. Drug: pawpaw. The Hebei Province Drug Quality Announcement (2019 Drug Supervision and Sampling Inspection No. 3), issued on October 12
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Jiangsu Yuanyang Pharmaceutical Co., Ltd. published October 12, 2019. Drug: pawpaw. The Hebei Province Drug Quality Announcement (2019 Drug Supervision and Sampling Inspection No. 3), issued on October 12
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox